Back to STATE STREET CORP STATE STREET CORP

ABCLABCL
20 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ABCELLERA BIOLOGICS INC

Yes. State Street holds 731,362 shares of ABCL (Abcellera Biologics), worth $5.7M, as of its Q2 2026 13F filing. It increased the position by 1,149 shares (+0.2%) from Q1 2026. State Street has held ABCL since Q3 2021, across 20 quarterly 13F filings.

Current Value

$5.7M

Current Shares

731,362

Total Value Change

+$3.2M

Total Shares Change

+604,894

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
731,362
+0.2%
$5.7M0.0%$7.85
27
2026-Q1
Increased
730,213
+5.2%
$2.5M0.0%$3.71
28
2025-Q4
Increased
694,114
+3.4%
$2.4M0.0%$3.45
27
2025-Q3
Increased
671,017
+9.2%
$3.4M0.0%$4.87
29
2025-Q2
Decreased
614,293
-2.0%
$2.1M0.0%$3.61
0
2025-Q1
Increased
627,141
+93.1%
$1.4M0.0%$2.31
40
2024-Q4
Increased
324,802
+0.5%
$951,6700.0%$2.82
17
2024-Q3
Increased
323,229
+1.5%
$840,3950.0%$2.61
17
2024-Q2
Decreased
318,550
-29.3%
$942,9080.0%$2.96
0
2024-Q1
Decreased
450,255
-2.3%
$2M0.0%$4.53
0
2023-Q4
Increased
460,900
+10.8%
$2.6M0.0%$5.71
29
2023-Q3
Increased
416,178
+64.9%
$1.9M0.0%$4.60
38
2023-Q2
Decreased
252,440
-92.5%
$1.6M0.0%$6.58
0
2023-Q1
Increased
3.4M
+3.7%
$25.6M0.0%$7.42
30
2022-Q4
Increased
3.3M
+1.8%
$33.1M0.0%$10.13
29
2022-Q3
Increased
3.2M
+0.5%
$31.8M0.0%$9.85
29
2022-Q2
Increased
3.2M
+1087.3%
$34M0.0%$10.11
47
2022-Q1
Increased
269,030
+50.1%
$2.6M0.0%$9.75
36
2021-Q4
Increased
179,207
+41.7%
$2.6M0.0%$14.34
35
2021-Q3
New
126,468
-
$2.5M0.0%$19.45
36

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used